The Evolving Landscape in the Management & Treatment of Multiple Sclerosis: Payer Considerations for Providing Support to People with MS and Their Care Partners
Jointly provided by Impact Education, LLC, the Multiple Sclerosis Association of America and Medical Education Resources, Inc.
Impact Education, LLC     Impact Education, LLC     Medical Education Resources
This activity is supported by independent educational grants from Biogen, Celgene Corporation and Genentech, Inc.

You Are Invited to a LIVE CME/CPE/CNE Webcast Series:
The Evolving Landscape in the Management & Treatment of Multiple Sclerosis: Payer Considerations for Providing Support to People with MS and Their Care Partners
Live Webcast

Live Webcast Dates

DAY DATE TIME
Wednesday October 16, 2019 12:30 PM - 2:00 PM ET
Thursday December 19, 2019 1:30 PM - 3:00 PM ET


EXPERT FACULTY PRESENTERS

Andrew Woo, MD, PhD
Assistant Clinical Professor of Neurology
David Geffen School of Medicine at UCLA
Santa Monica Neurological Consultants
James Kenney, RPh, MBA
Founder
JTKenney, LLC.
Edmund Pezalla, MD, MPH
CEO
Enlightenment Bioconsult, LLC.
Kyle Pinion
Senior Director of Education, Healthcare Relations & Advocacy
Multiple Sclerosis Association of America

TARGET AUDIENCE
  • Managed care pharmacy directors, clinical pharmacists, quality directors, medical directors and specialty pharmacists
  • Pharmacy directors, registered nurses, quality directors, care managers, and other managed care and payer organization professionals
PROGRAM OVERVIEW

The purpose of this webcast is to enhance the collaboration between managed care decision makers and multiple sclerosis (MS) specialists with the goal of improving the overall quality of care for patients with MS. We hope to reach this goal by bridging gaps in communication between managed care decision makers and these specialists, creating a dialogue, and allowing both groups to share their views on coverage decisions for MS patients.

EDUCATIONAL OBJECTIVES

After completing the activity, participants should be better able to:
  • Identify the clinic-economic impact of multiple sclerosis (MS)
  • Review the safety, efficacy of current and emerging MS therapies
  • Discuss the evolving advocacy and policy landscape impacting patients with MS
  • Explore utilization management and benefit design strategies for MS therapies to promote appropriate prescribing and enhance outcomes
AGENDA
Opening Comments/Overview
James Kenney, RPh, MBA
Clinical Update and Economic Impact of MS
Andrew Woo, MD, PhD
Evolving Advocacy and Policy Landscape Impacting Patients with MS
Edmund Pezalla, MD, MPH
Medical and Pharmacy Management Strategies to Enhance MS Patient Outcomes
James Kenney, RPh, MBA
MSAA Overview
Kyle Pinion
Audience Question and Answer Session

Key Takeaways and Closing Comments
ACCREDITATION INFORMATION

Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Education Resources, Inc. (MER) and Impact Education, LLC. MER is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Medical Education Resources, Inc. designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacy Credit
Medical Education Resources, Inc. (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MER designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: 0816-9999-19-176-L01-P
This activity is certified as Knowledge-based CPE.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.


Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources, Inc. to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
Name of Faculty Reported Financial Relationships
James Kenney, RPh, MBA No financial interest/relationships relating to the topic of this activity
Edmund Pezalla, MD, MPH No financial interest/relationships relating to the topic of this activity
Andrew Woo, MD, PhD Speakers' Bureau - Genentech, Novartis, Sanofi-Genzyme, EMD Serono

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
Name of Content Manager Reported Financial Relationships
Impact Education, LLC. Content Managers No financial interest/relationships relating to the topic of this activity
MER Content Managers No financial interest/relationships relating to the topic of this activity


Hardware/Software Requirements
Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.0, and Google Chrome 10 and up.

Fee Information
There is no fee for this educational activity.

Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.

If you have any questions, please call (215) 619-8812 or email info@impactedu.net.